Diabetes

Noctura 400 from PolyPhotonix offers a revolutionary, home-based non-invasive diabetic retinopathy treatment that reduces oxygen demand in the retina

A review of gene and genetic therapies for ophthalmic conditions – and what promises they hold

Could the CaMKII enzyme help preserve vision in patients with retinal disease and eye injuries?

Sitting Down With… Adam Mapani, Honorary Clinical Teaching Fellow UCL Department of Clinical Ophthalmology and Nurse Consultant at Moorfields

Sharing results from a real-world single center study of patients with diabetic macular oedema (DMO) who wore a home-use sleep mask (Noctura 400)

The light at the end of the tunnel for dry AMD and potential for other retinal diseases consists of a multiwavelength approach to stimulate cells

Leading epidemiologists give an overview of the status of vision loss in the seven super-regions of the world

VISION 2020: The Right to Sight – what’s next in the global challenge to reduce vision impairment and blindness?

The goal of ending global blindness may not have been reached yet, but technologically advanced and affordable diagnostics will help get us there

The latest eye-related research – in 60 words or less